ANGO – angiodynamics, inc. (US:NASDAQ)

News

AngioDynamics launches long-term study of NanoKnife for prostate cancer [Yahoo! Finance]
ANGO Stock Rises Following the Receipt of CPT Category I Code for IRE [Yahoo! Finance]
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
AngioDynamics' NanoKnife System gains CPT codes for prostate and liver treatments [Yahoo! Finance]
AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com